Zobrazeno 1 - 10
of 315
pro vyhledávání: '"Alfonso J. Cruz Jentoft"'
Autor:
Charlotte Beaudart, Céline Demonceau, Jean‐Yves Reginster, Médéa Locquet, Matteo Cesari, Alfonso J. Cruz Jentoft, Olivier Bruyère
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 14, Iss 3, Pp 1228-1243 (2023)
Abstract The decrease of physical abilities and functional decline that can be caused by musculoskeletal conditions such as sarcopenia, can lead to higher levels of dependency and disability. Therefore, it may influence patient reported outcome measu
Externí odkaz:
https://doaj.org/article/8cde6bc569644d4eae95f1f9672c96f2
Autor:
Alberto Pilotto, Nicola Veronese, Maria Cristina Polidori, Timo Strandberg, Eva Topinkova, Alfonso J. Cruz-Jentoft, Carlo Custodero, Stefania Maggi
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 2411-2419 (2022)
Background Literature suggests that different risks of mortality could influence physicians in prescribing or not anticoagulants in older patients with atrial fibrillation (AF). The Multidimensional Prognostic Index (MPI) can be considered a tool for
Externí odkaz:
https://doaj.org/article/4c66c8555996431da62ee49bf10d6a71
Autor:
Beatriz Montero-Errasquín, Nieves Vaquero-Pinto, Vicente Sánchez-Cadenas, Anton Geerinck, Elisabet Sánchez-García, Jesús Mateos-Nozal, José Manuel Ribera-Casado, Alfonso J. Cruz-Jentoft
Publikováno v:
BMC Musculoskeletal Disorders, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Background In 2015, a specific health-related quality of life questionnaire for sarcopenia, SarQoL®, was developed and validated in French. Since then, SarQoL® has been adapted and validated in different languages. We prepared a translatio
Externí odkaz:
https://doaj.org/article/d6a3e98523a94b6ea7d3a4d8a03e62c3
Autor:
Lorenzo M. Donini, Luca Busetto, Stephan C. Bischoff, Tommy Cederholm, Maria D. Ballesteros-Pomar, John A. Batsis, Juergen M. Bauer, Yves Boirie, Alfonso J. Cruz-Jentoft, Dror Dicker, Stefano Frara, Gema Frühbeck, Laurence Genton, Yftach Gepner, Andrea Giustina, Maria Cristina Gonzalez, Ho-Seong Han, Steven B. Heymsfield, Takashi Higashiguchi, Alessandro Laviano, Andrea Lenzi, Ibolya Nyulasi, Edda Parrinello, Eleonora Poggiogalle, Carla M. Prado, Javier Salvador, Yves Rolland, Ferruccio Santini, Mireille J. Serlie, Hanping Shi, Cornel C. Sieber, Mario Siervo, Roberto Vettor, Dennis T. Villareal, Dorothee Volkert, Jianchun Yu, Mauro Zamboni, Rocco Barazzoni
Publikováno v:
Obesity Facts, Pp 1-15 (2022)
Introduction: Loss of skeletal muscle mass and function (sarcopenia) is common in individuals with obesity due to metabolic changes associated with a sedentary lifestyle, adipose tissue derangements, comorbidities (acute and chronic diseases) and dur
Externí odkaz:
https://doaj.org/article/d1276094cfe743eb9365d15d78027e81
Autor:
Juergen Bauer, John E. Morley, Annemie M.W.J. Schols, Luigi Ferrucci, Alfonso J. Cruz‐Jentoft, Elsa Dent, Vickie E. Baracos, Jeffrey A. Crawford, Wolfram Doehner, Steven B. Heymsfield, Aminah Jatoi, Kamyar Kalantar‐Zadeh, Mitja Lainscak, Francesco Landi, Alessandro Laviano, Michelangelo Mancuso, Maurizio Muscaritoli, Carla M. Prado, Florian Strasser, Stephan vonHaehling, Andrew J.S. Coats, Stefan D. Anker
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 10, Iss 5, Pp 956-961 (2019)
Abstract The term sarcopenia was introduced in 1988. The original definition was a “muscle loss” of the appendicular muscle mass in the older people as measured by dual energy x‐ray absorptiometry (DXA). In 2010, the definition was altered to b
Externí odkaz:
https://doaj.org/article/62cadbfbbd06404488ffde701d802bc9
Autor:
Amanda H. Lavan, Denis O’Mahony, Paul Gallagher, Richard Fordham, Evelyn Flanagan, Darren Dahly, Stephen Byrne, Mirko Petrovic, Adalsteinn Gudmundsson, Olafur Samuelsson, Antonio Cherubini, Alfonso J. Cruz-Jentoft, Roy L. Soiza, Joseph A. Eustace
Publikováno v:
BMC Geriatrics, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background The aim of this trial is to evaluate the effect of SENATOR software on incident, adverse drug reactions (ADRs) in older, multimorbid, hospitalized patients. The SENATOR software produces a report designed to optimize older patient
Externí odkaz:
https://doaj.org/article/93bdf38d4c3b446e9682ced690dddc9c
Autor:
Marjolein Visser, Nuno Mendonça, Christina Avgerinou, Sibel Cavdar, Tommy Cederholm, Alfonso J. Cruz-Jentoft, Eva Kiesswetter, Hanna M. Siebentritt, Cornel Sieber, Gabriel Torbahn, Dorothee Volkert
Publikováno v:
Visser, M, Mendonça, N, Avgerinou, C, Cavdar, S, Cederholm, T, Cruz-Jentoft, A J, Kiesswetter, E, Siebentritt, H M, Sieber, C, Torbahn, G & Volkert, D 2023, ' A Core Outcome Set for nutritional intervention studies in older adults with malnutrition and those at risk : a study protocol ', BMC Geriatrics, vol. 23, 221, pp. 1-8 . https://doi.org/10.1186/s12877-023-03832-2
BMC Geriatrics, 23:221, 1-8. BioMed Central
BMC Geriatrics, 23:221, 1-8. BioMed Central
Background Malnutrition (i.e., protein-energy malnutrition) in older adults has severe negative clinical consequences, emphasizing the need for effective treatments. Many, often small, randomized controlled trials (RCTs) testing the effectiveness of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40d5df089b44c0114a936c9f3c22d65d
https://hdl.handle.net/1871.1/9776d6e7-fcb7-4710-961d-216d1a0958f4
https://hdl.handle.net/1871.1/9776d6e7-fcb7-4710-961d-216d1a0958f4
Publikováno v:
European Geriatric Medicine. 14:225-228
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44438e8a41ec2d10e37a0966a1d24f3e
https://doi.org/10.1007/s41999-023-00760-7
https://doi.org/10.1007/s41999-023-00760-7
Autor:
Josje D. Schoufour, Michael Tieland, Rocco Barazzoni, Somaya Ben Allouch, Joey van der Bie, Yves Boirie, Alfonso J. Cruz-Jentoft, Doris Eglseer, Eva Topinková, Bart Visser, Trudy Voortman, Amalia Tsagari, Peter J. M. Weijs
Publikováno v:
Frontiers in Nutrition, Vol 8 (2021)
The aging population faces two conditions that threaten healthy aging: high fat mass (obesity) and low muscle mass and function (sarcopenia). The combination of both—referred to as sarcopenic obesity—synergistically increases the risk of adverse
Externí odkaz:
https://doaj.org/article/6a4bd162fdad41ff9fe9b0e309d0822a
Autor:
Aurélie Ladang, Charlotte Beaudart, Jean-Yves Reginster, Nasser Al-Daghri, Olivier Bruyère, Nansa Burlet, Matteo Cesari, Antonio Cherubini, Mario Coelho da Silva, Cyrus Cooper, Alfonso J. Cruz-Jentoft, Francesco Landi, Andrea Laslop, Stefania Maggi, Ali Mobasheri, Sif Ormarsdottir, Régis Radermecker, Marjolein Visser, Maria Concepcion Prieto Yerro, René Rizzoli, Etienne Cavalier
Publikováno v:
Ladang, A, Beaudart, C, Reginster, J Y, Al-Daghri, N, Bruyère, O, Burlet, N, Cesari, M, Cherubini, A, da Silva, M C, Cooper, C, Cruz-Jentoft, A J, Landi, F, Laslop, A, Maggi, S, Mobasheri, A, Ormarsdottir, S, Radermecker, R, Visser, M, Yerro, M C P, Rizzoli, R & Cavalier, E 2023, ' Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia : Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging ', Calcified Tissue International, vol. 112, no. 2, pp. 197-217 . https://doi.org/10.1007/s00223-022-01054-z
In clinical trials, biochemical markers provide useful information on the drug’s mode of action, therapeutic response and side effect monitoring and can act as surrogate endpoints. In pharmacological intervention development for sarcopenia manageme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96344129cbd026e62eee402522f11e49
https://hdl.handle.net/1871.1/67454c5f-b78e-43a9-8aa8-05756b7ef2f4
https://hdl.handle.net/1871.1/67454c5f-b78e-43a9-8aa8-05756b7ef2f4